Mangalam Organic

  • Market Cap: Micro Cap
  • Industry: Commodity Chemicals
  • ISIN: INE370D01013
  • NSEID: MANORG
  • BSEID: 514418
INR
401.60
4.15 (1.04%)
BSENSE

Mar 05

BSE+NSE Vol: 511

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

511 (-74.96%) Volume

Shareholding (Dec 2025)

FII

0.00%

Held by 0 FIIs

DII

3.63%

Held by 0 DIIs

Promoter

58.65%

What does Mangalam Organic do?

06-Jun-2025

Mangalam Organics Ltd is a micro-cap company specializing in the manufacture of pine chemicals, particularly Terpenes and Synthetic Resins. As of March 2025, it reported net sales of ₹150 Cr and a net profit of ₹5 Cr.

Overview:<BR>Mangalam Organics Ltd is a leading manufacturer of pine chemicals, specifically in the sub-segments of Terpenes and Synthetic Resins, operating within the Commodity Chemicals industry and categorized as a Micro Cap company.<BR><BR>History:<BR>Incorporated in July 1981, Mangalam Organics was formerly known as Dujodwala Products Limited. The latest quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>- Net Sales: 150 Cr (Quarterly Results - Mar 2025)<BR>- Net Profit: 5 Cr (Quarterly Results - Mar 2025)<BR>- Market Cap: Rs 498 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: 41.00<BR>- Industry P/E: 47<BR>- Dividend Yield: 0.00%<BR>- Debt-Equity: 0.93<BR>- Return on Equity: 4.30%<BR>- Price to Book: 1.75<BR><BR>Contact Details:<BR>Address: Kumbhivali Vill Taluk Khalapur, Savroli Kharpada Road Khapoli Raigad Maharashtra : 410202<BR>Tel: 91-2192-276140<BR>Email: info@mangalamorganics.com<BR>Website: http://www.mangalamorganics.com

View full answer

Has Mangalam Organic declared dividend?

06-Jun-2025

Yes, Mangalam Organic has declared a dividend of 15% (₹1.5 per share) with an ex-date of September 20, 2022. However, the dividend yield is 0%, and total returns have varied significantly across different periods.

Mangalam Organic has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 15%<BR>- Amount per share: 1.5<BR>- Ex-date: 20 Sep 22<BR><BR>Dividend Yield: 0%<BR><BR>Total Returns by Period:<BR>In the 6-month period, the price return was 31.8%, with a dividend return of 0%, resulting in a total return of 31.8%.<BR><BR>For the 1-year period, the price return was 66.69%, with a dividend return of 0%, leading to a total return of 66.69%.<BR><BR>Over the 2-year period, the price return was 36.5%, with a dividend return of 0%, resulting in a total return of 36.5%.<BR><BR>In the 3-year period, the price return was -3.57%, with a dividend return of 0.28%, culminating in a total return of -3.29%.<BR><BR>For the 4-year period, the price return was -27.26%, with a dividend return of 0.39%, leading to a total return of -26.87%.<BR><BR>In the 5-year period, the price return was 81.79%, with a dividend return of 1.09%, resulting in a total return of 82.88%.<BR><BR>Overall, while Mangalam Organic has declared a dividend, the dividend yield remains at 0%. The total returns over various periods show significant variability, with strong performance in the 1-year and 5-year periods, but negative returns in the 3-year and 4-year periods.

View full answer

Who are the peers of the Mangalam Organic?

03-Jun-2025

Peers of Mangalam Organic include Tata Chemicals, Chemplast Sanmar, GHCL, India Glycols, Fischer Medical, OCCL, Andhra Petrochem, Kanoria Chem., and Lords Chloro. In terms of returns, India Glycols leads with 150.85% over one year, while Mangalam Organic has a return of 74.65%.

Peers: The peers of Mangalam Organic are Tata Chemicals, Chemplast Sanmar, GHCL, India Glycols, Fischer Medical, OCCL, Andhra Petrochem, Kanoria Chem., and Lords Chloro.<BR><BR>Quality Snapshot: Excellent management risk is observed at GHCL, while Good management risk is found at Chemplast Sanmar and the rest. Average management risk is present at Tata Chemicals, India Glycols, Mangalam Organic, Andhra Petrochem, and Lords Chloro, while Below Average management risk is noted at Fischer Medical and Kanoria Chem. OCCL does not qualify for management risk assessment. In terms of Growth, Excellent capital structure is noted at GHCL and Andhra Petrochem, while Average capital structure is found at Tata Chemicals, Mangalam Organic, Lords Chloro, and the rest. Below Average capital structure is observed at Chemplast Sanmar, India Glycols, Fischer Medical, and Kanoria Chem., while OCCL does not qualify.<BR><BR>Return Snapshot: India Glycols has the highest 1-year return at 150.85%, while Andhra Petrochem has the lowest at -44.65%. Mangalam Organic's 1-year return of 74.65% is significantly higher than Andhra Petrochem's but lower than India Glycols'. Additionally, Andhra Petrochem and National Perox. have negative six-month returns.

View full answer

Who are in the management team of Mangalam Organic?

16-Jul-2025

As of March 2023, the management team of Mangalam Organic includes Kamalkumar Dujodwala (Executive Chairman), Pannkaj Dujodwala (Managing Director), and several independent directors, with varying remuneration. They oversee the company's operations and strategic direction.

As of March 2023, the management team of Mangalam Organic includes the following individuals:<BR><BR>1. Kamalkumar Dujodwala - Executive Chairman (Remuneration: INR 3.0 crore)<BR>2. Pannkaj Dujodwala - Managing Director (Remuneration: INR 3.0 crore)<BR>3. Sharad Saraf - Independent Director (Remuneration: INR 18,000)<BR>4. Manisha Agarwal - Independent Director (Remuneration: INR 21,000)<BR>5. Sanjay Bhiva Kadam - Independent Director (Remuneration: INR 15,000)<BR>6. Sidharath Singh Sekhon - Independent Director (Remuneration: INR 3,000)<BR>7. Nitin Kore - Company Secretary & Compliance Officer (Remuneration: INR 0)<BR><BR>This team is responsible for overseeing the operations and strategic direction of the company.

View full answer

Who are the top shareholders of the Mangalam Organic?

17-Jul-2025

The top shareholders of Mangalam Organic include Tradechem Organics Limited with 21.36%, followed by public shareholder Radhakishan S Damani at 2.17%. Individual investors hold 30.2% of the shares, with no pledged promoter holdings or mutual funds/foreign institutional investors involved.

The top shareholders of Mangalam Organic include the promoters, with Tradechem Organics Limited holding the largest stake at 21.36%. Additionally, Radhakishan S Damani is the highest public shareholder, owning 2.17% of the company. Individual investors collectively hold 30.2% of the shares. Notably, there are no pledged promoter holdings, and the company does not have any mutual funds or foreign institutional investors (FIIs) holding shares.

View full answer

How big is Mangalam Organic?

24-Jul-2025

As of 24th July, Mangalam Organics Ltd has a market capitalization of 420.00 Cr, with recent net sales of 530.02 Cr and a net profit of 12.60 Cr. The balance sheet for March 2024 shows shareholder's funds of 280.71 Cr and total assets of 483.06 Cr.

As of 24th July, Mangalam Organics Ltd has a market capitalization of 420.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Mangalam Organics reported Net Sales of 530.02 Cr and a Net Profit of 12.60 Cr.<BR><BR>The latest annual period for the balance sheet is March 2024, showing Shareholder's Funds of 280.71 Cr and Total Assets of 483.06 Cr.

View full answer

Is Mangalam Organic technically bullish or bearish?

19-Aug-2025

As of 18 August 2025, the trend has shifted to bullish with moderate strength, driven by positive monthly MACD signals and moving averages, although short-term caution is advised due to mildly bearish weekly indicators.

As of 18 August 2025, the technical trend has changed from mildly bullish to bullish. The current stance is bullish with moderate strength. Key indicators driving this include a bullish signal from the monthly MACD and moving averages on the daily timeframe. Additionally, Bollinger Bands are bullish on both the weekly and monthly charts. However, the weekly MACD and KST are mildly bearish, indicating some caution in the short term. Overall, the monthly indicators suggest a stronger bullish sentiment, supported by positive returns compared to the Sensex across multiple time frames.

View full answer

Is Mangalam Organic overvalued or undervalued?

29-Aug-2025

As of August 28, 2025, Mangalam Organic is considered undervalued with an attractive valuation grade, supported by a PE ratio of 20.48 and strong growth potential, especially when compared to peers like Godrej Industries and others that have significantly higher valuations.

As of 28 August 2025, the valuation grade for Mangalam Organic has moved from fair to attractive, indicating a positive shift in its perceived value. The company is currently considered undervalued. Key ratios supporting this conclusion include a PE ratio of 20.48, an EV to EBITDA of 10.75, and a PEG ratio of 0.07, which suggests strong growth potential relative to its price.<BR><BR>In comparison to its peers, Mangalam Organic's valuation appears favorable. For instance, Godrej Industries, which is also rated attractive, has a significantly higher PE ratio of 41.86 and an EV to EBITDA of 31.72, highlighting Mangalam's relative affordability. Other peers like Solar Industries and Gujarat Fluorochemicals are categorized as very expensive, with PE ratios of 99.06 and 60.27, respectively. Additionally, despite a recent decline in stock price, Mangalam Organic has shown a solid YTD return of 25.67%, outperforming the Sensex's 2.48% during the same period, reinforcing its undervalued status.

View full answer

How has been the historical performance of Mangalam Organic?

01-Dec-2025

Mangalam Organic has shown positive growth in net sales and profitability from March 2020 to March 2025, with net sales increasing to 530.01 crore and profit after tax reaching 12.60 crore. However, the company faces challenges with rising raw material costs and negative cash flow in March 2025.

Answer:<BR>The historical performance of Mangalam Organic shows a fluctuating trend in key financial metrics over the years.<BR><BR>Breakdown:<BR>Mangalam Organic's net sales have increased from 374.52 crore in March 2020 to 530.01 crore in March 2025, indicating a positive growth trajectory. Total operating income has followed a similar pattern, rising from 374.52 crore in March 2020 to 530.01 crore in March 2025. However, raw material costs have also risen significantly, from 209.70 crore in March 2020 to 312.47 crore in March 2025. The operating profit (PBDIT) saw a notable recovery, moving from a loss of 2.43 crore in March 2023 to a profit of 58.91 crore in March 2025. Profit before tax improved from a loss of 33.76 crore in March 2023 to a profit of 16.62 crore in March 2025, and profit after tax also turned positive, reaching 12.60 crore in March 2025 from a loss of 27.22 crore in March 2023. The company's total liabilities increased from 311.30 crore in March 2021 to 623.60 crore in March 2025, reflecting a rise in both long-term and short-term borrowings. Cash flow from operating activities turned negative in March 2025 at -7.00 crore, contrasting with a positive cash flow of 73.00 crore in March 2024. Overall, while Mangalam Organic has shown growth in sales and profitability, it faces challenges with rising costs and cash flow management.

View full answer

Should I buy, sell or hold Mangalam Organic?

11-Dec-2025

When is the next results date for Mangalam Organics Ltd?

04-Feb-2026

The next results date for Mangalam Organics Ltd is 12 February 2026.

The next results date for Mangalam Organics Ltd is scheduled for 12 February 2026.

View full answer

Are Mangalam Organics Ltd latest results good or bad?

13-Feb-2026

Mangalam Organics Ltd's latest results show strong revenue and net profit growth, but declining operating and profit margins, along with rising interest expenses and high debt levels, raise concerns about the sustainability of this growth. Investors should consider these mixed signals when evaluating the company's performance.

Mangalam Organics Ltd's latest results present a mixed picture. On one hand, the company has shown significant growth in revenue and net profit for Q3 FY26. Revenue reached ₹164.30 crores, marking a 32.59% increase year-on-year and a 3.92% rise from the previous quarter. Net profit also improved to ₹4.33 crores, up 34.89% quarter-on-quarter.<BR><BR>However, this positive topline growth is overshadowed by concerning trends in profitability. The operating margin has declined to 11.75% from 14.74% in the previous quarter, indicating margin compression due to rising costs. Additionally, the profit after tax margin has dropped sharply to 2.64% from 8.35%, reflecting challenges in maintaining profitability despite increased sales.<BR><BR>The company's financial health is further complicated by rising interest expenses, which reached a record ₹8.07 crores, and a high debt-to-equity ratio of 1.14. This suggests that while the company is growing its revenue, it faces significant operational challenges and financial strain.<BR><BR>In summary, while Mangalam Organics has achieved impressive revenue and profit growth, the deterioration in margins and rising leverage raise concerns about the sustainability of this growth. Investors should weigh these factors carefully when assessing the company's performance.

View full answer

Why is Mangalam Organics Ltd falling/rising?

04-Mar-2026

As of 04-Mar, Mangalam Organics Ltd's stock price is declining, currently at 405.70, with a downward trend over the last nine days and trading below all key moving averages. The stock has seen significant losses, including a -11.92% drop in the past month and a -17.71% decline year-to-date.

As of 04-Mar, Mangalam Organics Ltd's stock price is falling, currently at 405.70, reflecting a change of -1.2 (-0.29%). The stock has been on a downward trend, experiencing consecutive losses for the last nine days, during which it has declined by -3.99%. Today, it opened with a loss of -2.14% and reached an intraday low of Rs 392.25, which is a decrease of -3.6%. <BR><BR>Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Investor participation has also decreased, with delivery volume dropping by -10.75% compared to the 5-day average. Overall, these factors contribute to the stock's decline, as it has shown negative performance over various time frames, including a -11.92% drop over the past month and a -17.71% decline year-to-date.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Poor long term growth as Operating profit has grown by an annual rate -16.28% of over the last 5 years

 
2

Below par performance in long term as well as near term

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Commodity Chemicals

stock-summary
Market cap

INR 344 Cr (Micro Cap)

stock-summary
P/E

13.00

stock-summary
Industry P/E

38

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

1.13

stock-summary
Return on Equity

8.72%

stock-summary
Price to Book

1.13

Revenue and Profits:
Net Sales:
164 Cr
(Quarterly Results - Dec 2025)
Net Profit:
4 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-18.87%
0%
-18.87%
6 Months
-29.91%
0%
-29.91%
1 Year
-3.23%
0%
-3.23%
2 Years
14.14%
0%
14.14%
3 Years
-2.74%
0%
-2.74%
4 Years
-52.65%
0.17%
-52.48%
5 Years
-25.12%
0.58%
-24.54%

Latest dividend: 1.5 per share ex-dividend date: Sep-20-2022

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

Announcements stock-summary

Announcement under Regulation 30 (LODR)-Newspaper Publication

18-Feb-2026 | Source : BSE

Newspaper Publication for Special Window Intimation for Transfer and Dematerialisation of physical securities prior to April 01 2019

Announcement under Regulation 30 (LODR)-Investor Presentation

14-Feb-2026 | Source : BSE

Investor Presentation for the quarter ended December 31 2025

Announcement under Regulation 30 (LODR)-Newspaper Publication

13-Feb-2026 | Source : BSE

Please find the attached Newspaper clippings for the quarterly financial results of December 31 2025.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Mangalam Organics Ltd has declared 15% dividend, ex-date: 20 Sep 22

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
13.81%
EBIT Growth (5y)
-16.28%
EBIT to Interest (avg)
16.67
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
1.13
Sales to Capital Employed (avg)
1.07
Tax Ratio
19.52%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
3.63%
ROCE (avg)
12.70%
ROE (avg)
9.32%

Valuation key factors

Factor
Value
P/E Ratio
13
Industry P/E
38
Price to Book Value
1.13
EV to EBIT
18.23
EV to EBITDA
11.45
EV to Capital Employed
1.06
EV to Sales
1.13
PEG Ratio
0.07
Dividend Yield
NA
ROCE (Latest)
5.37%
ROE (Latest)
8.72%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Tradechem Organics Limited (21.36%)

Highest Public shareholder

Radhakishan S Damani (2.17%)

Individual Investors Holdings

28.72%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 3.92% vs 7.88% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 34.89% vs -73.75% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "164.30",
          "val2": "158.10",
          "chgp": "3.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "19.30",
          "val2": "0.26",
          "chgp": "7,323.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "8.07",
          "val2": "7.00",
          "chgp": "15.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-3.51",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "4.33",
          "val2": "3.21",
          "chgp": "34.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.75%",
          "val2": "0.16%",
          "chgp": "11.59%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 18.87% vs -7.74% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 304.19% vs 306.38% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "304.66",
          "val2": "256.30",
          "chgp": "18.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "21.88",
          "val2": "23.20",
          "chgp": "-5.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "12.73",
          "val2": "8.10",
          "chgp": "57.16%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-3.51",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "15.44",
          "val2": "3.82",
          "chgp": "304.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "7.18%",
          "val2": "9.05%",
          "chgp": "-1.87%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 23.34% vs -2.11% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 165.01% vs 305.43% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "468.96",
          "val2": "380.22",
          "chgp": "23.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "41.18",
          "val2": "38.91",
          "chgp": "5.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "20.80",
          "val2": "13.93",
          "chgp": "49.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-3.51",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "19.77",
          "val2": "7.46",
          "chgp": "165.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "8.78%",
          "val2": "10.23%",
          "chgp": "-1.45%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 7.39% vs 0.20% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 193.71% vs 115.76% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "530.01",
          "val2": "493.52",
          "chgp": "7.39%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "58.58",
          "val2": "38.67",
          "chgp": "51.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "21.48",
          "val2": "15.62",
          "chgp": "37.52%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "12.60",
          "val2": "4.29",
          "chgp": "193.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.05%",
          "val2": "7.84%",
          "chgp": "3.21%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
164.30
158.10
3.92%
Operating Profit (PBDIT) excl Other Income
19.30
0.26
7,323.08%
Interest
8.07
7.00
15.29%
Exceptional Items
0.00
-3.51
100.00%
Consolidate Net Profit
4.33
3.21
34.89%
Operating Profit Margin (Excl OI)
11.75%
0.16%
11.59%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is 3.92% vs 7.88% in Sep 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is 34.89% vs -73.75% in Sep 2025

Half Yearly Results Snapshot (Consolidated) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
304.66
256.30
18.87%
Operating Profit (PBDIT) excl Other Income
21.88
23.20
-5.69%
Interest
12.73
8.10
57.16%
Exceptional Items
-3.51
0.00
Consolidate Net Profit
15.44
3.82
304.19%
Operating Profit Margin (Excl OI)
7.18%
9.05%
-1.87%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 18.87% vs -7.74% in Sep 2024

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2025 is 304.19% vs 306.38% in Sep 2024

Nine Monthly Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
468.96
380.22
23.34%
Operating Profit (PBDIT) excl Other Income
41.18
38.91
5.83%
Interest
20.80
13.93
49.32%
Exceptional Items
-3.51
0.00
Consolidate Net Profit
19.77
7.46
165.01%
Operating Profit Margin (Excl OI)
8.78%
10.23%
-1.45%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is 23.34% vs -2.11% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2025 is 165.01% vs 305.43% in Dec 2024

Annual Results Snapshot (Consolidated) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
530.01
493.52
7.39%
Operating Profit (PBDIT) excl Other Income
58.58
38.67
51.49%
Interest
21.48
15.62
37.52%
Exceptional Items
0.00
0.00
Consolidate Net Profit
12.60
4.29
193.71%
Operating Profit Margin (Excl OI)
11.05%
7.84%
3.21%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 7.39% vs 0.20% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 193.71% vs 115.76% in Mar 2024

stock-summaryCompany CV
About Mangalam Organics Ltd stock-summary
stock-summary
Mangalam Organics Ltd
Micro Cap
Commodity Chemicals
Mangalam Organics Limited (formerly known as Dujodwala Products Limited) was incorporated in July, 1981. The Company is a leading pine chemicals manufacturer in the sub-segments of Terpenes and Synthetics Resins which is a single segment as chemicals. The Company is in the business of manufacturing chemical and has Terpenes and Synthetic Resins as primary segment. The company came out with a Rs 8.7 Cr. public issue in Jun.
Company Coordinates stock-summary
Company Details
Kumbhivali Vill Taluk Khalapur, Savroli Kharpada Road Khapoli Raigad Maharashtra : 410202
stock-summary
Tel: 91-2192-276140
stock-summary
info@mangalamorganics.com
Registrar Details
Mondkar Computers Pvt Ltd , 21 Shakil Niwas , Opp. Satya Saibaba Temple, Mahakali Caves Road, Andheri (E), Mumbai